Navigation Links
Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer


Measure mutations in any tissue with the Big Blue transgenic rodent mutation assay

Johan G. de Boer Barry W. Glickman
Centre for Environmental Health, University of Victoria, Victoria, BC Canada

With Stratagenes Big Blue transgenic rodent mutation assay,* which carries the E. coli lacI transgene in a retrievable chromosomally integrated shuttle vector, it is easy to study mutations in male and female mice or rats of any age under selected conditions in vivo. Multilab studies indicate that mutations are generally induced in the same tissue that tumors are produced but not in nontarget tissues. This makes the transgenic model for the study of genotoxicity even more valuable, since mutations can be studied in virtually any tissue.

The hallmark of occupational- and lifestyle-related cancer is tissue specificity. Human exposures to carcinogens result in particular types of cancer at predictable sites; tobacco smoke, arsenic, and ionizing radiation all produce their own unique kinds of cancers in preferred tissues. Tissue specificity is also a feature of animal model systems. For example, when male mice are exposed to the flame retardant tris(2,3-dibromopropyl)phosphate (TDBP), they contract kidney tumors, and the alkylating agent dimethylnitrosamine predominantly produces liver, kidney, and lung tumors. Sex can also have an impact on tissue targeting. In the case of TDBP, liver tumors predominate in female mice, while kidney tumors are seen in male mice.

Figure 1

This kind of information is crucial for identifying suspected carcinogens. Hence, we ask a critical question: Does mutation follow the same pattern as the targeting of tumors? In other words, are mutations being induced in tissues where tumors are recovered and not in others? Big Blue transgenic rodents with recoverable mutation target genes make use of the well-characterized bacterial lacI gene as a mutational target gene. The lacI gene, part of the lLIZ shuttle vector, is present in approximately 40 copies per chromosome in the mouse and rat. Mutations are efficiently assessed through the recovery of the l genome (Figure 1). High molecular weight genomic DNA is isolated from any selected Big Blue transgenic rodent tissue, which can be facilitated with the RecoverEase DNA isolation kit, and the l genomes are packaged into phage particles by Transpack lambda packaging extract.** The l particles are then plated on a specially constructed E. coli host in the presence of the chromogenic compound X-gal. Phages carrying the mutated lacI gene produce blue plaques, whereas the wild-type gene yields colorless plaques.

The ratio of blue to clear plaques indicates the mutant frequency, which in most tissues varies between 2 to 6 x 10-5, although it is often lower in the rat than the mouse. Subsequent sequencing of the mutant lacI genes reveals the specific nature of the DNA change at the molecular level; when a sufficient number of mutants have been sequenced, a mutational spectrum results. Mutational spectra are extremely useful in assessing the mechanism of mutation. DNA sequencing also permits the mutant frequency to be adjusted by allowing a correction for clonal expansion in which an individual mutation is recovered multiple times because of cell division.

Tissue Specific Effects

Researchers who have designed studies to assess mutations in a range of tissues after carcinogen treatment have addressed whether mutations are induced selectively in those tissues targeted for tumorigenesis. We reviewed some of the available data to illustrate how the Big Blue transgenic rodent mutagenesis assay system is used in tissue-specific studies (Table 1).

Table 1
Induction of Tumors and Mutations in Target and Nontarget Tissues by Selected Carcingens

Compound

Tumor target

Mutations

No mutations

DMN2,3

Liver, kidney, lung

Liver, kidney, lung

Bladder, bone marrow, testis

TDBP1

Kidney

Kidney, liver

Stomach

PhIP*

Colon

Colon

Liver

MeIQ10

Colon, liver, skin, mammary gland

Colon, liver, skin, mammary gland

Heart

Ethylene oxide7

lung

lung

Spleen, bone marrow, germ cells

Benzene8

Lung, leukemia, lymphomas

Lung, spleen

liver

* De Boer et al., unpublished
See text for additional details.

TDBP

The flame retardant tris(2,3-dibromopropyl)phosphate (TDBP) is an established kidney-specific carcinogen in male and female rats and male mice; in female mice, it targets the liver. In a TDBP study,1 the lacI mutation frequency was determined in the kidney, liver, and stomach of male Big Blue mice after treatment with 2000 ppm of TDBP. The mutant frequency increased marginally in the kidney and liver (approximately 50%) but not the stomach. Sequencing the mutants revealed a unique difference in mutational spectrum: The spectrum from the liver was indistinguishable from that of untreated animals, while that from the kidney included unique deletions of single GC base pairs. Thus, in this case, TDBP-specific mutations were induced only in the tissue where tumors were recovered. Hence, DNA sequencing can improve the assay sensitivity in situations where the induced mutant frequency is low.

DMN

Tissue specificity was also observed with dimethylnitrosamine (DMN), which has been well studied in the liver.2 DMN produces tumors in various organs including the liver, kidney, and lung. Suzuki et al.3 observed mutation induction in each of these tissues (6.2, 2.4, and 2.1 fold, respectively). In contrast, they observed no statistically significant mutation induction in nontarget tissues such as the urinary bladder (1.7 x 10-5 versus 1.4 x 10-5 in controls), testis (0.39 x 10-5 versus 0.48 x 10-5 in controls), and bone marrow (1.7 x 10-5 versus 1.3 x 10-5 in controls).

MeIQ

MeIQ (2-amino-3,4-dimethylimidazo[4,5-f ]quinoline) is a potent heterocyclic amine found in the human diet. MeIQ induces tumors in several rat tissues including colon, skin, mammary gland, oral cavity; in the mouse it forms tumors of the forestomach and liver. Several publications have shown that MeIQ induced mutations in Big Blue transgenic rodents.4,5 Induced mutations have been observed in each target tissue except the heart, which is not a target for tumorigenesis. Ushijima et al.5 determined the DNA sequence alterations in mutants recovered from the liver (approximately a 4.5-fold increase in mutant frequency) and bone marrow (approximately a 5-fold increase). A significant tissue-specific difference was seen in the mutant fractions that were GC to TA transversions: 37% in the liver versus only 14% in bone marrow. Consequently, both sequencing DNA and determining mutant frequency are important for more accurately assessing mutation induction and mechanism.

PhIP

PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) is a colon carcinogen in the male rat but does not cause tumors in the liver. It induced a 20-fold increase in colon mutations after 400 ppm PhIP was added to the diet.6 We recently determined that no mutations above background are induced in the liver of these animals (de Boer, et al., unpublished). DNA adducts are found in the colon but not the liver. PhIP is metabolically activated in the liver by cytochrome P450, but additional metabolic processing takes place in colon cells.

Ethyleneoxide and Benzene

Sisk et al.7 studied mutation induction in lacI transgenic mice after the mice inhaled 200 ppm of ethylene oxide. The mutant frequency increased significantly in the lung (9.1 x 10-5 versus 6.2 x 10-5 in the controls) but not the spleen, bone marrow, and male germ cells. The lung is indeed a major target organ for tumor formation in the mouse. In another mouse inhalation study with benzene,8 which induces lung tumors, leukemia, and lymphomas, mutations significantly increased in the lung and spleen (a 1.7- and 1.5-fold increase, respectively) but not in the liver tissue. Benzene metabolism takes place partially in the liver, while final oxidation steps can take place in the bone marrow.

Conclusions

The Big Blue transgenic rodent assay system accurately predicts mutations in specific tissues. In a number of cases, mutations are recovered in tissues that are not targets for carcinogenesis. While this eases the screening for mutagenic compounds, it becomes more difficult to determine mutagenic mechanisms and how they relate to carcinogenesis.9 For example, we recently determined that mutation induction in the kidney after TDBP treatment is highest in the cortex layer and less in the outer and inner medulla (de Boer, et al., in preparation). Tumors, however, do not arise in the cortex but in the outer medulla layer. This and other findings indicate that cell proliferation is equally important for tissue-specific tumor formation.

REFERENCES
  1. De Boer, J.G., et al.(1996) Environ. Mol. Mutagen. 28: 418-423.

  2. Mirsalis, J.C., et al.(1993) Mutagenesis 8: 265-271.

  3. Suzuki, T., et al. (1996) Environ. Mol. Mutagen. 28: 348-353.

  4. Suzuki, T., et al. (1996) Mutat. Res. 369: 45-49.

  5. Ushijima, T., et al. (1994) Carcinogenesis 15: 2805-2809.

  6. Okonogi, H., et al. (1997) Mutat. Res. 395: 93-99.

  7. Sisk, S.C., et al. (1997) Mutat. Res. 391: 153-164.

  8. Mullin, A.H., et al. (1995) Mutat. Res. 327: 121-129.

  9. Gorelick, N.J., (1996) Prog. Clin. Biol. Res. 395: 81-108.

  10. Ushijima, T., et al. (1994) Carcinogenesis 15: 2805-2809.

* U.S. Patent No. 5,347,075 and 5,589,155; European Patent No. 0289121;
Japanese Patent No. 2618973.
** U.S. Patent No. 5,188,957.


'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. Innovative Tissue Array Technology for High-Throughput Screening of Gene Expression
2. Detecting Gastrin-Releasing Peptide Receptor by in situ PCR on Archived Tissue
3. Simple Isolation of RNA from Tissue and Cultured Cells
4. Hands-free Tissue Disruption No Homogenization Needed
5. Recover High Yields of Total Nucleic Acid from Formalin-fixed, Paraffin-embedded (FFPE) Tissue
6. RNase Activity in Mouse Tissue: Classification, Hierarchy, and Methods for Control
7. Stabilizing RNA in Fresh and Frozen Tissues for RNA Isolation
8. Genomic DNA Preparation from RNAlater Preserved Tissues
9. DNA Isolation From 300 to 450 mg Dried or 600 to 1,200 mg Fresh Leaf Tissue
10. DNA Isolation From 50 to 20 mg of Paraffin-Embedded Tissue
11. Genomic DNA Isolation From 510 mg Marine Invertebrate Tissue
Post Your Comments:
(Date:1/15/2014)... RedBrick Health , a fast-growing leader in consumer health ... EmblemHealth , the New York -based ... RedBrick Compass health assessment, combined with the RedBrick Journeys ... EmblemHealth is among the first health plans in the ...
(Date:1/15/2014)... 15, 2014 More than 5 million ... 1 in 3 seniors will die with Alzheimer’s or ... jaw-dropping figures have shocked many Americans into looking for ... prevent these tragic age-related cognitive disorders. Jonathan Weisman, president ...
(Date:1/15/2014)... 15, 2014 DTS Language Services, Inc ... Web Portal for Life Science organizations who need document translations. ... subject matter of their documents in advance with a selection ... time-to-delivery of translations, often a critical factor in clinical and ...
(Date:1/15/2014)... AudioNotch is the internet's leading provider of Notched Sound ... Patients listen to sound therapy that is tailor-made for ... to months, their tinnitus volume decreases. , AudioNotch has previously ... Notched White Noise. Now, AudioNotch is pleased to announce to ...
Breaking Biology Technology:EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2DTS Improves Efficiency for Life Science Document Translations 2
... http://www.thirdbiotech.com ), a biotechnology incubator and life ... the ThirdBiotech Research,Group including a drug discovery ... of collaborative activities between researchers,and industry for ... (Logo: http://www.newscom.com/cgi-bin/prnh/20070911/LATU119LOGO ), "Over ...
... 25 The U.S. Food and Drug,Administration ... Drugs,voted to recommend the approval of tolvaptan, ... treatment,for patients with hyponatremia., "Otsuka is ... the,potential approval of tolvaptan, an investigational selective,V2-vasopressin ...
... is,strengthening its customer-focused biomarker services portfolio to,pharmaceutical, ... Xie will lead those efforts as Battelle,s ... a suite of biomarker services, including biomarker,discovery, ... clients,better define molecular mechanisms of diseases, toxicity, ...
Cached Biology Technology:ThirdBiotech Launches Research Institute to Promote Formation and Growth of Arizona-Based Biotech Companies 2U.S. Food and Drug Administration Advisory Committee Recommends Approval of Tolvaptan, an Investigational Treatment for Hyponatremia 2Battelle Selects Xie to Develop Biomarker Services 2
(Date:4/18/2014)... PROVIDENCE, R.I. [Brown University] Asteroid and comet impacts ... animals on regional or even global scales. But new ... preserve the signatures of ancient life at the time ... Brown geologist Pete Schultz has found fragments of leaves ... a several ancient impacts in Argentina. The material could ...
(Date:4/17/2014)... trials to treat tuberculosis could be the basis for ... bacteria, fungal infections and parasites, yet evade resistance, according ... collaborators. , Led by U. of I. chemistry professor ... drug SQ109 attacks the tuberculosis bacterium, how the drug ... to malaria and how targeting multiple pathways reduces ...
(Date:4/17/2014)... April 17, 2014The development of stem cell therapies to ... to characterize stem cell populations based on cell surface ... a new marker that is highly expressed in a ... blood, which they describe in an article in ... Ann Liebert, Inc., publishers. The article is available free ...
Breaking Biology News(10 mins):Impact glass stores biodata for millions of years 2Impact glass stores biodata for millions of years 3Multitarget TB drug could treat other diseases, evade resistance 2
... their native language of 1 and 0 absolutes but struggle ... While scientists are making slow, incremental progress in their quest ... body language, a more straightforward method of communication may help ... of researchers led by Charlie Kemp, director of the Center ...
... the equatorial Pacific long before Europeans arrived in the ... the way from modern-day Chile to western Mexico, according ... of Materials Science and Engineering. Details of ... years ago were reconstructed largely through the efforts of ...
... is a conspicuous and exaggerated display shaped by sexual ... attraction. At the level of the individual, song is ... Laiolo and colleagues at the Spanish Council of Research ... in north-eastern Spain and found an association between individual ...
Cached Biology News:Robot fetches objects with just a point and a click 2Robot fetches objects with just a point and a click 3Robot fetches objects with just a point and a click 4Floating a big idea: MIT demos ancient use of rafts to transport goods 2Floating a big idea: MIT demos ancient use of rafts to transport goods 3Floating a big idea: MIT demos ancient use of rafts to transport goods 4
... The University of New South Wales, Sydney, Australia ... Australia This is the Fourth Edition of this ... is a large format version (330 x ... 3rd edition. This product number includes the ...
For absolute protein quantification. 4 peptides in 5 vials x 2 nmol per peptide...
... The Jouan RC10 series of vacuum concentrators/centrifugal ... protection features allied to rapid and safe ... can be combined with oil-free or high ... and a wide selection of rotors (eliminating ...
Monoclonal mouse antibody for immunihistology, clone AD12, Isotype IgG 1, purified, specific for rat pyruvatekinase type L, no cross-reactivities with other pyruvate kinase isoenzymes have been obser...
Biology Products: